1. Leveraging a Y. lipolytica naringenin chassis for biosynthesis of apigenin and associated glucoside.
- Author
-
Marsan CB, Lee SG, Nguyen A, Gordillo Sierra AR, Coleman SM, Brooks SM, and Alper HS
- Subjects
- Glucosides biosynthesis, Glucosides metabolism, Apigenin metabolism, Apigenin biosynthesis, Flavanones biosynthesis, Flavanones metabolism, Yarrowia metabolism, Yarrowia genetics, Metabolic Engineering, Escherichia coli metabolism, Escherichia coli genetics
- Abstract
Flavonoids are a diverse set of natural products with promising bioactivities including anti-inflammatory, anti-cancer, and neuroprotective properties. Previously, the oleaginous host Yarrowia lipolytica has been engineered to produce high titers of the base flavonoid naringenin. Here, we leverage this host along with a set of E. coli bioconversion strains to produce the flavone apigenin and its glycosylated derivative isovitexin, two potential nutraceutical and pharmaceutical candidates. Through downstream strain selection, co-culture optimization, media composition, and mutant isolation, we were able to produce168 mg/L of apigenin, representing a 46% conversion rate of 2-(R/S)-naringenin to apigenin. This apigenin platform was modularly extended to produce isovitexin by addition of a second bioconversion strain. Together, these results demonstrate the promise of microbial production and modular bioconversion to access diversified flavonoids., (Copyright © 2024 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF